RA disease affects biomarkers like IL-18, MIC-1, and ICAM-1, linking RA with subclinical atherosclerosis.Elevated levels of these biomarkers may indicate increased cardiovascular disease (CVD) risk in RA patients. This evidence concerns the gene ICAM1 and cardiovascular disorder.